Tokyo, Japan

Hiroyuki Okudaira

This inventor holds 1 USPTO granted patent. Top assignees: National Hospital Organization, Nihon Medi-Physics Company, Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroyuki Okudaira. Retrieved from https://idiyas.com/inventor/hiroyuki-okudaira

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroyuki Okudaira: Innovator in Medicinal Chemistry

Introduction

Hiroyuki Okudaira is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patent work. His expertise and dedication to research have led to advancements in pharmaceutical compounds.

Latest Patents

Hiroyuki Okudaira holds a patent for a compound known as 2-[5-(imidazol-1-ylmethyl)pyridin-3-yl]benzimidazole derivative compound, which includes a medicament incorporating this compound. This invention is represented by a specific formula where various elements can be substituted, showcasing his innovative approach to medicinal chemistry. He has 1 patent to his name.

Career Highlights

Throughout his career, Hiroyuki has worked with prominent organizations such as Nihon Medi-Physics Company, Limited and the National Hospital Organization. His roles in these companies have allowed him to apply his research in practical settings, contributing to the development of medical technologies.

Collaborations

Hiroyuki has collaborated with esteemed colleagues, including Akihiro Izawa and Yuki Okumura. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.

Conclusion

Hiroyuki Okudaira's contributions to medicinal chemistry through his patent work and collaborations highlight his role as an influential inventor. His dedication to advancing pharmaceutical compounds continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…